Intrinsic antitachycardia pacing (iATP) is a novel, automated antitachycardia pacing (ATP)
algorithm that provides individualized therapy to terminate ventricular tachycardia (VT). If the …

Cardiac arrhythmia is associated with high morbidity, and its underlying mechanisms are
poorly understood. Computational modelling and simulation approaches have the potential …

Background Antitachycardia pacing (ATP) success rates as low as 50% for fast ventricular
tachycardias (VTs) have been reported providing an opportunity for improved ATP to …

Background Antitachycardia pacing (ATP) is an established implantable cardioverter-
defibrillator (ICD) therapy that terminates ventricular tachycardias (VTs) without painful ICD …

Intrinsic anti-tachycardia pacing (iATP) is a novel automated ATP algorithm that employs
post-pacing interval (PPI) to design the next ATP sequence based on an analysis of the prior …

Implantable cardioverter-defibrillators (ICDs) serve to reduce the risk of sudden death;
however, ICD shocks worsen patient prognosis. Therefore, attempts have been made to …

Intrinsic antitachycardia pacing (iATP) is a novel automated ventricular ATP algorithm that
designs ATP sequences based on the analysis of prior failed ATP. Real‐world data on the …

Implantable cardioverter defibrillators (ICDs) have a long history and have progressed
significantly since the 1980s. They have become an essential part of the prevention of …

Abstract Purpose of Review Implantable cardioverter-defibrillator (ICD) shocks, whether
appropriate or inappropriate, are associated with significant morbidity and mortality. Anti …

We report the usefulness of novel automated anti-tachycardia pacing (ATP) for ventricular
tachycardia (VT) termination evaluated in an electrophysiology study. This intrinsic …